Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transdermal estrogen vs desmopressin to prevent uremic bleeding during kidney biopsy in chronic kidney disease
TCTR20220419012Phase 3Active, not recruiting
- Sponsor
- King Chulalongkorn Memorial Hospital
- Start
- Sep 2020
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic kidney disease (CKD) and uremia comparing Transdermal estrogen with Desmopressin (2 arms). Started Sep 2020; status: active, not recruiting.
02
Drugs
DehydraTECH-estrogendesmopressin
03
Conditions
chronic kidney disease (CKD)uremia
Beyond the preview
Go deeper on TCTR20220419012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220419012.